MARKET ACCESS & PRICING

 

 

Market Access & Pricing, Wednesday 9 December 2020

Panel discussion
09:00

Keynote Panel: Fostering innovation through partnerships

Moderator: Rajendra Srivastava, Dean and Novartis Professor of Marketing Strategy and Innovation, Indian School Of Business
Anand Gautam, Executive Director & Emerging Science Lead, Emerging Science & Innovation (ES&I), Asia & Asia-Pacific (ANZ), Pfizer Worldwide R&D
Vern De Biasi, Vice President, Global Head of Strategic Partnerships, Cyclica Inc.
Melissa Saw, Global Head Of Digital Partnerships, Bayer
Damian O'Connell, Chief Executive Officer Experimental Drug Development Centre, A*STAR
Dr Daniel Liu
Market Access & Pricing
10:00

Overview of IND/NDA process in China

Dr Daniel Liu, Chief Scientific Officer, Clinical Service Center
Jack Wong
Market Access & Pricing
10:30

Introduction of medical device regulatory system in Asia – challenges and tips for quicker registration

Jack Wong, Founder of ARPA, Asia Regulatory Professionals Association and Head of RA, MOW, Biocon Biologics
Andrea Latour
Market Access & Pricing
11:00

Panel: Adapting to the changing market access landscape

Moderator: Andrea Latour, Head of Health Economics and HTA, Vista Health
Chris Hardesty, Director, Healthcare & Life Sciences, KPMG
Hang Le, Foundation Medicine Access Lead, Roche
Hitesh Chandwani, Regional (Asia-Pacific) Market Access Director, Janssen Asia-Pacific
Finny Liu, APAC Regional Regulatory Policy Lead, Roche Singapore Pte Ltd
Vikas Tripathi, Head - Global Business Development, Polisano Pharmaceuticals
Panel discussion
Market Access & Pricing
12:00

Panel: How do we rethink the delivery of universal healthcare – providing equitable access to patients post Covid-19?

Moderator: Anand Jha, Managing Director, Ansea
Jek Fong, Director, Patient Access and Personalised Healthcare, Roche
Karen Ida Villanueva, Board Member, Philippine Alliance of Patient Organizations and International Alliance of Patients Organizations
Dr Alexander Zach, Global Head Market Access, Policy & Pricing, Biocon Biologics
Market Access & Pricing
13:00

Networking break

Pritha Aggarwal
Market Access & Pricing
13:30

Making antibodies affordable for all

Pritha Aggarwal, Manager, IAVI
Dr Alexander Zach
Market Access & Pricing
14:00

Access to care for NCDs: Going big with biosimilars

Dr Alexander Zach, Global Head Market Access, Policy & Pricing, Biocon Biologics
Sekar Sakthivel
Market Access & Pricing
14:30

Panel: Treating stakeholders and payers like customers

Moderator: Sekar Sakthivel, Head, Industry Development, Enterprise Industry Cluster/Singapore Bioimaging Consortium, A*STAR
Devmanyu Singh, Foundation Medicine Transformation Lead, Roche Pharma International
Rajakanth Raman, Principal Consultant, Manifeste LLP, and Executive Director, Rainbow Across Borders Limited
Anand Jha
Market Access & Pricing
15:30

Moving from market access to patient access from a payer’s perspective

Anand Jha, Managing Director, Ansea
Shailendra Bajpai
Market Access & Pricing
16:00

Forming a collaborative relationship with stakeholders and payers

Shailendra Bajpai, Global Head Of Disease Management And Key Stakeholder Engagement, Diabetes and CV Emerging Markets, Sanofi
last published: 09/Dec/20 03:45
BOOK NOW

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738